313 related articles for article (PubMed ID: 22110136)
1. Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.
Yu ED; Girardi E; Wang J; Mac TT; Yu KO; Van Calenbergh S; Porcelli SA; Zajonc DM
J Biol Chem; 2012 Jan; 287(2):1269-78. PubMed ID: 22110136
[TBL] [Abstract][Full Text] [Related]
2. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode.
Li Y; Girardi E; Wang J; Yu ED; Painter GF; Kronenberg M; Zajonc DM
J Exp Med; 2010 Oct; 207(11):2383-93. PubMed ID: 20921281
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis for recognition of CD1d/α-galactosylceramide by a human non-Vα24 T cell receptor.
López-Sagaseta J; Kung JE; Savage PB; Gumperz J; Adams EJ
PLoS Biol; 2012; 10(10):e1001412. PubMed ID: 23109910
[TBL] [Abstract][Full Text] [Related]
4. Structure-Function Implications of the Ability of Monoclonal Antibodies Against α-Galactosylceramide-CD1d Complex to Recognize β-Mannosylceramide Presentation by CD1d.
Clark K; Yau J; Bloom A; Wang J; Venzon DJ; Suzuki M; Pasquet L; Compton BJ; Cardell SL; Porcelli SA; Painter GF; Zajonc DM; Berzofsky JA; Terabe M
Front Immunol; 2019; 10():2355. PubMed ID: 31649670
[TBL] [Abstract][Full Text] [Related]
5. Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci DG; Patel O; Kjer-Nielsen L; Pang SS; Sullivan LC; Kyparissoudis K; Brooks AG; Reid HH; Gras S; Lucet IS; Koh R; Smyth MJ; Mallevaey T; Matsuda JL; Gapin L; McCluskey J; Godfrey DI; Rossjohn J
Immunity; 2009 Jul; 31(1):47-59. PubMed ID: 19592275
[TBL] [Abstract][Full Text] [Related]
6. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of bovine CD1d reveal altered αGalCer presentation and a restricted A' pocket unable to bind long-chain glycolipids.
Wang J; Guillaume J; Pauwels N; Van Calenbergh S; Van Rhijn I; Zajonc DM
PLoS One; 2012; 7(10):e47989. PubMed ID: 23110152
[TBL] [Abstract][Full Text] [Related]
8. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
11. A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties.
Uldrich AP; Patel O; Cameron G; Pellicci DG; Day EB; Sullivan LC; Kyparissoudis K; Kjer-Nielsen L; Vivian JP; Cao B; Brooks AG; Williams SJ; Illarionov P; Besra GS; Turner SJ; Porcelli SA; McCluskey J; Smyth MJ; Rossjohn J; Godfrey DI
Nat Immunol; 2011 Jun; 12(7):616-23. PubMed ID: 21666690
[TBL] [Abstract][Full Text] [Related]
12. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors.
Pellicci DG; Clarke AJ; Patel O; Mallevaey T; Beddoe T; Le Nours J; Uldrich AP; McCluskey J; Besra GS; Porcelli SA; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2011 Jul; 12(9):827-33. PubMed ID: 21804559
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
[TBL] [Abstract][Full Text] [Related]
14. Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.
Brennan PJ; Cheng TY; Pellicci DG; Watts GFM; Veerapen N; Young DC; Rossjohn J; Besra GS; Godfrey DI; Brenner MB; Moody DB
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8348-8353. PubMed ID: 28716901
[TBL] [Abstract][Full Text] [Related]
15. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
16. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
17. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.
Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM
Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602
[TBL] [Abstract][Full Text] [Related]
18. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
19. Self-glycerophospholipids activate murine phospholipid-reactive T cells and inhibit iNKT cell activation by competing with ligands for CD1d loading.
Halder RC; Tran C; Prasad P; Wang J; Nallapothula D; Ishikawa T; Wang M; Zajonc DM; Singh RR
Eur J Immunol; 2019 Feb; 49(2):242-254. PubMed ID: 30508304
[TBL] [Abstract][Full Text] [Related]
20. Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.
Patel O; Pellicci DG; Uldrich AP; Sullivan LC; Bhati M; McKnight M; Richardson SK; Howell AR; Mallevaey T; Zhang J; Bedel R; Besra GS; Brooks AG; Kjer-Nielsen L; McCluskey J; Porcelli SA; Gapin L; Rossjohn J; Godfrey DI
Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19007-12. PubMed ID: 22065767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
